Compare Mutual Funds
Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 2/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 6 Months | 7 Years 11 Months | ||
Fund AUM | ₹8365 Cr | ₹6669 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.93% | 1.05% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 43 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 2 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 98.68% | 96.76% | ||
Debt % | - | - | ||
P/E | 35.41 | 33.84 | ||
P/B | 5.64 | 4.23 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 8.24% | 9.44% | ||
3-Month Return | 8.68% | 10.96% | ||
6-Month Return | 5.43% | 3.32% | ||
1-Year Return | 10.69% | 11.26% | ||
3-Year Return | 25.22% | 29.59% | ||
5-Year Return | 14.77% | 17.46% |
Sharpe | 1.01 | 1.2 | ||
Alpha | -0.24 | 2.84 | ||
Beta | 0.91 | 0.97 | ||
Standard Deviation | 15.78 | 16.85 | ||
Information Ratio | -0.55 | 0.73 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania | Dharmesh Kakkad, Sharmila D’mello |

